Neuronascent is focused on the discovery and development of therapies for Alzheimer's disease, depression, and stroke based on the science of neurogenesis that:

• Reduce the loss of neurons
• Restore and replace damaged neurons
• Promote the formation of new neurons
• Reverse cognitive loss

Come join us February 19-20 at the Wharton Health Care Business Conference in Philadelphia, PA

 

10.08 - Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeautic Programs

06.08 - President and CSO presents at International Society for Neurochemistry

01.08 - State of Maryland Dept of Business and Economic Development awards Challenge Fund grant


[home] [about us] [technology] [R&D programs] [news & events] [contact us]
NeuroNascent, Inc. - All Rights Reserved - site by TeraMark, LLC